191 related articles for article (PubMed ID: 25618179)
1. The expanding role of co-trimoxazole in developing countries.
Church JA; Fitzgerald F; Walker AS; Gibb DM; Prendergast AJ
Lancet Infect Dis; 2015 Mar; 15(3):327-39. PubMed ID: 25618179
[TBL] [Abstract][Full Text] [Related]
2. Co-trimoxazole prophylaxis for children who are HIV-exposed and uninfected: a systematic review.
Wedderburn CJ; Evans C; Slogrove AL; Rehman AM; Gibb DM; Prendergast AJ; Penazzato M
J Int AIDS Soc; 2023 Jun; 26(6):e26079. PubMed ID: 37292018
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa.
Bwakura-Dangarembizi M; Kendall L; Bakeera-Kitaka S; Nahirya-Ntege P; Keishanyu R; Nathoo K; Spyer MJ; Kekitiinwa A; Lutaakome J; Mhute T; Kasirye P; Munderi P; Musiime V; Gibb DM; Walker AS; Prendergast AJ
N Engl J Med; 2014 Jan; 370(1):41-53. PubMed ID: 24382064
[TBL] [Abstract][Full Text] [Related]
4. Scaling-up co-trimoxazole prophylaxis in HIV-exposed and HIV-infected children in high HIV-prevalence countries.
Zachariah R; Harries AD; Luo C; Bachman G; Graham SM
Lancet Infect Dis; 2007 Oct; 7(10):686-93. PubMed ID: 17897611
[TBL] [Abstract][Full Text] [Related]
5. Co-trimoxazole prophylaxis in adults, including pregnant women, with HIV: a systematic review and meta-analysis.
Suthar AB; Vitoria MA; Nagata JM; Anglaret X; Mbori-Ngacha D; Sued O; Kaplan JE; Doherty MC
Lancet HIV; 2015 Apr; 2(4):e137-50. PubMed ID: 26424674
[TBL] [Abstract][Full Text] [Related]
6. Role of co-trimoxazole for urinary tract infections in developing countries.
Leblebicioglu H; Ozaras R; Sunbul M
Lancet Infect Dis; 2015 Jul; 15(7):764-5. PubMed ID: 26122444
[No Abstract] [Full Text] [Related]
7. Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort.
Walker AS; Ford D; Gilks CF; Munderi P; Ssali F; Reid A; Katabira E; Grosskurth H; Mugyenyi P; Hakim J; Darbyshire JH; Gibb DM; Babiker AG
Lancet; 2010 Apr; 375(9722):1278-86. PubMed ID: 20347483
[TBL] [Abstract][Full Text] [Related]
8. Level of understanding of co-trimoxazole use among HIV infected, recurrent pulmonary tuberculosis suspects at a national referral tuberculosis clinic in Kampala, Uganda: a qualitative analysis.
Okwera A; Mafigiri DK; Guwatudde D; Whalen C; Joloba M
Afr Health Sci; 2015 Mar; 15(1):49-57. PubMed ID: 25834530
[TBL] [Abstract][Full Text] [Related]
9. Protective efficacy of co-trimoxazole prophylaxis against malaria in HIV exposed children in rural Uganda: a randomised clinical trial.
Sandison TG; Homsy J; Arinaitwe E; Wanzira H; Kakuru A; Bigira V; Kalamya J; Vora N; Kublin J; Kamya MR; Dorsey G; Tappero JW
BMJ; 2011 Mar; 342():d1617. PubMed ID: 21454456
[TBL] [Abstract][Full Text] [Related]
10. Initiating co-trimoxazole prophylaxis in HIV-infected patients in Africa: an evaluation of the provisional WHO/UNAIDS recommendations.
Badri M; Ehrlich R; Wood R; Maartens G
AIDS; 2001 Jun; 15(9):1143-8. PubMed ID: 11416716
[TBL] [Abstract][Full Text] [Related]
11. Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d'Ivoire: a trial-based analysis.
Yazdanpanah Y; Losina E; Anglaret X; Goldie SJ; Walensky RP; Weinstein MC; Toure S; Smith HE; Kaplan JE; Freedberg KA;
AIDS; 2005 Aug; 19(12):1299-308. PubMed ID: 16052085
[TBL] [Abstract][Full Text] [Related]
12. Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda.
Mermin J; Lule J; Ekwaru JP; Malamba S; Downing R; Ransom R; Kaharuza F; Culver D; Kizito F; Bunnell R; Kigozi A; Nakanjako D; Wafula W; Quick R
Lancet; 2004 Oct 16-22; 364(9443):1428-34. PubMed ID: 15488218
[TBL] [Abstract][Full Text] [Related]
13. Effect of co-trimoxazole prophylaxis on morbidity and mortality of HIV-exposed, HIV-uninfected infants in South Africa: a randomised controlled, non-inferiority trial.
Daniels B; Coutsoudis A; Moodley-Govender E; Mulol H; Spooner E; Kiepiela P; Reddy S; Zako L; Ho NT; Kuhn L; Ramjee G
Lancet Glob Health; 2019 Dec; 7(12):e1717-e1727. PubMed ID: 31708152
[TBL] [Abstract][Full Text] [Related]
14. Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study.
Mermin J; Ekwaru JP; Liechty CA; Were W; Downing R; Ransom R; Weidle P; Lule J; Coutinho A; Solberg P
Lancet; 2006 Apr; 367(9518):1256-61. PubMed ID: 16631881
[TBL] [Abstract][Full Text] [Related]
15. Revisiting Co-trimoxazole Prophylaxis for African Adults in the Era of Antiretroviral Therapy: A Randomized Controlled Clinical Trial.
Laurens MB; Mungwira RG; Nampota N; Nyirenda OM; Divala TH; Kanjala M; Mkandawire FA; Galileya LT; Nyangulu W; Mwinjiwa E; Downs M; Tillman A; Taylor TE; Mallewa J; Plowe CV; van Oosterhout JJ; Laufer MK
Clin Infect Dis; 2021 Sep; 73(6):1058-1065. PubMed ID: 33744963
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of malaria and anaemia among HIV infected pregnant women receiving co-trimoxazole prophylaxis in Tanzania: a cross sectional study in Kinondoni Municipality.
Manyanga VP; Minzi O; Ngasala B
BMC Pharmacol Toxicol; 2014 Apr; 15():24. PubMed ID: 24761799
[TBL] [Abstract][Full Text] [Related]
17. Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy.
Crook AM; Turkova A; Musiime V; Bwakura-Dangarembizi M; Bakeera-Kitaka S; Nahirya-Ntege P; Thomason M; Mugyenyi P; Musoke P; Kekitiinwa A; Munderi P; Nathoo K; Prendergast AJ; Walker AS; Gibb DM;
BMC Med; 2016 Mar; 14():50. PubMed ID: 27004529
[TBL] [Abstract][Full Text] [Related]
18. Protective efficacy of prolonged co-trimoxazole prophylaxis in HIV-exposed children up to age 4 years for the prevention of malaria in Uganda: a randomised controlled open-label trial.
Homsy J; Dorsey G; Arinaitwe E; Wanzira H; Kakuru A; Bigira V; Muhindo M; Kamya MR; Sandison TG; Tappero JW
Lancet Glob Health; 2014 Dec; 2(12):e727-36. PubMed ID: 25433628
[TBL] [Abstract][Full Text] [Related]
19. Effect of early chemoprophylaxis with co-trimoxazole on nutritional status evolution in HIV-1-infected adults in Abidjan, Côte d'Ivoire.
Castetbon K; Anglaret X; Attia A; Toure S; Dakoury-Dogbo N; Messou E; N'Dri-Yoman T; Dabis F; Salamon R;
AIDS; 2001 May; 15(7):869-76. PubMed ID: 11399959
[TBL] [Abstract][Full Text] [Related]
20. Outcome from treatment of Pneumocystis jirovecii pneumonia with co-trimoxazole.
Fisk M; Sage EK; Edwards SG; Cartledge JD; Miller RF
Int J STD AIDS; 2009 Sep; 20(9):652-3. PubMed ID: 19710343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]